HPV Infographics Summary
1Pages

HPV is one of the most common SEXUALLY TRANSMITTED infections in Australia1,2 HPV PREVALENCE HPV16 and HPV18 cause up to 76.1% of cervical cancers in Australia1 2 3 HPV ACCOUNTS FOR 5% OF ALL CANCERS WORLDWIDE HIGH RISK TYPES OF HPV CAUSE: 99.7% cervical cancer cases4 5 CERVICAL CANCER IN AUSTRALIA, IT IS ESTIMATED THAT EACH YEAR: About 793 new cases of cervical cancer are DIAGNOSED3 About 303 women die from cervical cancer6 HPV TRANSMISSION RISKS WITH ULTRASOUND PROBES HPV can survive and remain infectious on surfaces for days even when treated with common . . . , Up to 7% of ultrasound probes remain Ultrasound probes infectious on surfaces for days, contaminatecl with ligh-riskHPV HPV is highly resistant to Independent laboratory testing disinfectants types after ultrasound disinfection and routine disinfection7"9 are a potential source of disinfectants commonly used on shows trophorfEPR kills HPV infection ultrasound probes 6. Ryndock EJ, Meyers C., A risk for non-sexual transmission of human papilloma virus? Expert Rev. Anti Infect. Ther. 12(10), 1165-1170 (2014). 7. Casalegno et. AL: High Risk HPV Contamination of Endocavity Vaginal Ultrasound Probes: An Underestimated Route of Nosocomial Infection?, PLOS ONE, Oct 2012, Volume 7, Issue 10. 8. M’Zali et al. Persistence of microbial contamination on transvaginal ultrasound probes despite low-level disinfection procedure. PLoS One 2014;9:e93368. 9. Leroy, S et al. Impact of Vaginal-Rectal Ultrasound Examinations with Covered and Low-Level Disinfected Transducers on Infectious Transmissions in France. Infection Control and Hospital Epidemiology, Vol 35, No 12 (December 2014), pp.1497-1504. 10. Meyers, J., et al., Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother, 2014. 11. Ryndock E, Burdach J, Weinberger R, Robison R, Meyers C. The efficacy of an automated ultrasound probe disinfector against high-risk human papillomavirus (2015) SHEA Spring 2015. Orlando, Rorida; poster presentation. Nanosonics Limited (Manufacturer) 14 Mars Road Lane Cove NSW 2066 Australia T: + 61 2 8063 1600 I E: info@nanosonics.com.au I www.nanosonics.com.auBiodecon Limited (Distributor) 5 Argus Place Glenfield Auckland 0627 New Zealand T: +64 9 442 4025 I E: nfo@biodecon.co.nz I www.biodecon.co.nz © 2015 Nanosonics Limited. All rights reserved. Australian Government Department of Health, HPV human papillomavirus. http://www.health.gov.au/internet/sti/publishing.nsf/Content/hpv (Accessed June 2015). National Centre for Immunisation Research and Surveillance (NCIRS). Human papillomavirus (HPV) vaccines for Australians I NCIRS Fact sheet: March 2013. Bruni L, et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Australia. Summary Report 2015- 03-20. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12 19. Parkin DM (2006). 'The global health burden of infection-associated cancers in the year 2002". Int. J. Cancer 118 (12): 3030 44.